Hyperoxia: Causes, Effects, and Clinical Management

Hyperoxia is a condition characterized by an excessive level of oxygen in the blood and tissues, most often resulting from the administration of supplemental oxygen at high concentrations. While oxygen is essential for cellular metabolism and survival, it must be used carefully in clinical practice.

Excessive oxygen exposure can lead to harmful physiologic effects, particularly within the lungs and central nervous system.

In respiratory care, oxygen is treated as a medication that requires precise dosing, monitoring, and adjustment to avoid complications associated with overuse.

What Is Hyperoxia?

Hyperoxia refers to a state in which arterial oxygen tension (PaO₂) is elevated beyond normal physiologic levels. This typically occurs when patients receive high fractions of inspired oxygen (FiO₂), especially for prolonged periods.

Under normal conditions, oxygen is delivered to tissues at levels sufficient to meet metabolic demands without causing harm. However, when oxygen levels exceed what the body can safely handle, toxic effects may develop.

In clinical settings, hyperoxia is most commonly associated with oxygen therapy. Devices such as nasal cannulas, simple face masks, nonrebreather masks, and mechanical ventilators can deliver varying concentrations of oxygen. While these devices are essential for treating hypoxemia, they can also contribute to hyperoxia if not carefully titrated.

Oxygen as a Drug

A fundamental principle in respiratory care is that oxygen should be treated as a drug. This means it must be prescribed with a specific indication, dose, and target range. Unlike many medications, oxygen is often administered rapidly and sometimes without strict limits, particularly in emergency situations. However, excessive administration can lead to unintended consequences.

Proper oxygen therapy involves:

• Identifying the indication for oxygen use
• Selecting the appropriate delivery device
• Setting a target oxygen saturation or PaO₂ range
• Monitoring the patient’s response
• Adjusting the FiO₂ as needed

Note: The goal is to provide enough oxygen to maintain adequate tissue oxygenation while avoiding excessive exposure.

Pathophysiology of Hyperoxia

The harmful effects of hyperoxia are primarily related to the production of reactive oxygen species (ROS). Under normal physiologic conditions, oxygen participates in cellular respiration within the mitochondria, producing energy in the form of adenosine triphosphate (ATP). During this process, small amounts of ROS are generated and neutralized by the body’s antioxidant systems.

When oxygen levels become excessively high, the production of ROS increases significantly. These molecules include:

• Superoxide anions
• Hydrogen peroxide
• Hydroxyl radicals

These reactive substances can damage cellular components such as lipids, proteins, and DNA. This process, known as oxidative stress, leads to inflammation and tissue injury.

The lungs are particularly vulnerable because they are directly exposed to high oxygen concentrations. Prolonged exposure can result in oxygen-induced lung injury, also referred to as hyperoxic acute lung injury (HALI).

Pulmonary Effects of Hyperoxia

Oxygen Toxicity

Pulmonary oxygen toxicity is one of the most significant complications of hyperoxia. It typically develops when patients are exposed to high FiO₂ levels, often greater than 0.60, for extended periods. The severity of toxicity depends on both the concentration of oxygen and the duration of exposure.

Key features of pulmonary oxygen toxicity include:

• Inflammation of lung tissue
• Damage to alveolar epithelial cells
• Injury to the pulmonary capillary endothelium
• Increased permeability of the alveolar-capillary membrane

Note: These changes can lead to pulmonary edema, reduced gas exchange, and impaired lung function.

Diffuse Alveolar Damage

With ongoing exposure, hyperoxia can cause diffuse alveolar damage. This condition is characterized by:

• Thickening of the alveolar walls
• Loss of surfactant function
• Accumulation of fluid in the alveoli

Note: As a result, the lungs become less compliant, making ventilation more difficult. Patients may experience increased work of breathing and worsening oxygenation despite receiving high levels of supplemental oxygen.

Decreased Lung Compliance

One of the clinical consequences of hyperoxia-induced lung injury is decreased lung compliance. This means the lungs become stiffer and more difficult to expand. Reduced compliance can complicate mechanical ventilation and increase the risk of ventilator-associated complications.

Absorption Atelectasis

Absorption atelectasis is another important mechanism associated with hyperoxia. Under normal conditions, nitrogen makes up a significant portion of inspired air and helps maintain alveolar stability by acting as a structural support.

When a patient breathes high concentrations of oxygen, nitrogen is displaced from the alveoli. Oxygen is rapidly absorbed into the bloodstream, leaving the alveoli without sufficient gas to maintain their structure. This can lead to alveolar collapse.

Consequences of absorption atelectasis include:

• Reduced surface area for gas exchange
• Worsening ventilation-perfusion mismatch
• Decreased oxygenation despite high FiO₂

Note: This phenomenon highlights the importance of avoiding unnecessarily high oxygen concentrations.

Central Nervous System Effects

Although less common in routine oxygen therapy, hyperoxia can also affect the central nervous system. These effects are more likely to occur in environments with elevated atmospheric pressure, such as hyperbaric oxygen therapy.

Excess oxygen can alter neuronal activity and lead to neurologic symptoms, including:

• Visual disturbances
• Tinnitus
• Nausea
• Muscle twitching
• Seizures

Note: These symptoms are related to increased oxidative stress within the brain and changes in neuronal excitability. While rare in standard clinical settings, these effects are important to recognize in specialized environments.

Hyperoxia and Respiratory Drive

Hypoxic Drive in COPD

In healthy individuals, breathing is primarily regulated by carbon dioxide levels through central chemoreceptors. However, in some patients with chronic obstructive pulmonary disease (COPD), long-standing elevations in PaCO₂ can blunt the sensitivity of these receptors.

As a result, these patients may rely more on low oxygen levels to stimulate breathing, a mechanism known as hypoxic drive.

When high levels of oxygen are administered:

• The hypoxic stimulus is reduced
• Respiratory rate may decrease
• Ventilation can decline
• Carbon dioxide retention may worsen

Note: This can lead to hypercapnia and respiratory acidosis, which can be dangerous if not recognized and managed appropriately.

Clinical Implications

It is important to note that oxygen should not be withheld from patients who need it. Instead, it should be carefully titrated to achieve target oxygen saturation levels, often between 88 percent and 92 percent in patients with COPD.

Monitoring is essential to ensure that oxygen therapy improves oxygenation without causing unintended suppression of ventilation.

Clinical Risk Factors for Hyperoxia

Certain clinical situations increase the risk of developing hyperoxia. These include:

Mechanical Ventilation

Patients receiving mechanical ventilation are at high risk because ventilators can deliver precise and often high concentrations of oxygen. Without careful adjustment, patients may remain on elevated FiO₂ levels longer than necessary.

High-Concentration Oxygen Devices

Devices such as nonrebreather masks can deliver very high oxygen concentrations. These are useful in emergency situations but should be used cautiously and for limited durations.

Critical Illness

Patients in intensive care settings often require aggressive oxygen therapy due to severe hypoxemia. While this is necessary for stabilization, prolonged exposure increases the risk of oxygen toxicity.

Lack of Monitoring

Failure to regularly assess oxygenation status can lead to prolonged exposure to excessive oxygen levels. Continuous monitoring using pulse oximetry and periodic arterial blood gas analysis is essential.

Monitoring Oxygen Therapy

Effective management of hyperoxia relies on careful monitoring. Clinicians must assess both oxygenation and ventilation to ensure appropriate therapy.

Pulse Oximetry

Pulse oximetry provides a noninvasive method for monitoring oxygen saturation (SpO₂). It allows for continuous assessment and helps guide adjustments in oxygen therapy. However, pulse oximetry has limitations. It does not provide information about carbon dioxide levels and may not detect hyperoxia directly.

Arterial Blood Gas Analysis

Arterial blood gas (ABG) analysis provides detailed information about:

• PaO₂
• PaCO₂
• pH
• Bicarbonate levels

Note: This information is essential for identifying hyperoxia, hypercapnia, and acid-base disturbances.

Clinical Assessment

In addition to objective measurements, clinicians should monitor for changes in:

• Respiratory rate
• Work of breathing
• Mental status

Note: A decrease in respiratory rate or level of consciousness in a patient receiving oxygen may indicate excessive oxygen administration.

Principles of Prevention

Preventing hyperoxia requires a proactive approach to oxygen therapy. Key strategies include:

• Using the lowest effective FiO₂
• Setting target oxygen saturation ranges
• Regularly reassessing the patient’s condition
• Reducing oxygen concentration as soon as possible

Note: This approach ensures that patients receive adequate oxygenation without unnecessary exposure to high oxygen levels.

Clinical Management of Hyperoxia

Effective management of hyperoxia focuses on reducing excessive oxygen exposure while maintaining adequate tissue oxygenation. The key principle is titration, which involves adjusting oxygen delivery to meet the patient’s needs without exceeding safe levels.

Oxygen Titration

Oxygen should be adjusted based on clearly defined clinical targets. These targets typically include:

• Maintaining SpO₂ within a prescribed range
• Achieving adequate PaO₂ on arterial blood gas analysis
• Preventing signs of hypoxemia

For most patients, an SpO₂ of 92 percent to 96 percent is appropriate. In patients with chronic lung disease, such as COPD, a lower target range of 88 percent to 92 percent is often recommended to reduce the risk of carbon dioxide retention.

Frequent reassessment is necessary to ensure that oxygen levels remain within the desired range. Once the patient stabilizes, FiO₂ should be reduced as quickly as clinically feasible.

Use of Positive End-Expiratory Pressure (PEEP)

Positive end-expiratory pressure is commonly used in patients receiving mechanical ventilation to improve oxygenation without increasing FiO₂. PEEP helps maintain alveolar recruitment by preventing alveolar collapse at the end of expiration.

Benefits of PEEP include:

• Improved ventilation-perfusion matching
• Increased functional residual capacity
• Reduced risk of absorption atelectasis

Note: By improving oxygenation through alveolar recruitment, clinicians can often decrease the required FiO₂, thereby reducing the risk of hyperoxia.

Mechanical Ventilation Considerations

Patients on mechanical ventilation are at particular risk for hyperoxia due to the ability of ventilators to deliver high oxygen concentrations. Careful ventilator management is essential.

Key considerations include:

• Avoiding prolonged use of FiO₂ greater than 0.60 when possible
• Gradually weaning FiO₂ as oxygenation improves
• Using adjunct strategies such as PEEP or recruitment maneuvers
• Monitoring arterial blood gases regularly

Note: Ventilator settings should be optimized to support adequate ventilation and oxygenation while minimizing lung injury. This includes maintaining appropriate tidal volumes and pressures to prevent further damage to already vulnerable lung tissue.

Avoiding Prolonged High Oxygen Exposure

The duration of oxygen exposure is just as important as the concentration. Even moderate elevations in FiO₂ can become harmful if maintained for extended periods.

Strategies to reduce exposure time include:

• Promptly transitioning from high-concentration devices to lower-flow systems
• Discontinuing oxygen therapy when no longer needed
• Using room air trials to assess the patient’s ability to maintain adequate oxygenation

Note: This approach reduces the cumulative effects of oxygen exposure and lowers the risk of toxicity.

Special Populations

Certain patient populations require additional caution when administering oxygen therapy due to their increased susceptibility to the effects of hyperoxia.

Patients with COPD

As discussed earlier, patients with COPD may rely on hypoxic drive for ventilation. Excessive oxygen administration can suppress their respiratory effort and lead to carbon dioxide retention.

Management strategies include:

• Using controlled oxygen delivery devices, such as Venturi masks
• Targeting lower oxygen saturation ranges
• Monitoring for signs of hypoventilation and rising PaCO₂

Neonates

Premature infants are particularly vulnerable to oxygen toxicity. High oxygen levels can contribute to conditions such as retinopathy of prematurity and bronchopulmonary dysplasia.

In neonatal care:

• Oxygen levels are carefully titrated to narrow target ranges
• Continuous monitoring is essential
• Even small deviations in oxygen concentration can have significant effects

Critically Ill Patients

Patients in intensive care units often require high levels of oxygen support. While necessary, this increases the risk of hyperoxia.

Management in these patients focuses on:

• Frequent reassessment of oxygen needs
• Early use of lung-protective strategies
• Minimizing FiO₂ while maintaining adequate oxygenation

Complications of Hyperoxia

Hyperoxia can lead to several complications, particularly when exposure is prolonged.

Pulmonary Complications

The lungs are the primary site of injury. Complications include:

• Oxygen toxicity
• Diffuse alveolar damage
• Pulmonary edema
• Decreased lung compliance

Note: These changes can impair gas exchange and prolong the need for respiratory support.

Absorption Atelectasis

As previously discussed, high oxygen concentrations can lead to alveolar collapse. This reduces effective ventilation and may worsen hypoxemia despite high FiO₂.

Hypercapnia

In susceptible patients, particularly those with COPD, hyperoxia can lead to carbon dioxide retention. This occurs due to reduced ventilatory drive and worsening ventilation-perfusion mismatch.

Central Nervous System Effects

Although uncommon in standard clinical settings, CNS toxicity can occur in high-pressure environments. Symptoms may include seizures and other neurologic disturbances.

Hyperoxia in Clinical Practice

In everyday clinical practice, hyperoxia is often an unrecognized issue. Oxygen is frequently administered liberally, especially in emergency situations, without immediate adjustment once the patient stabilizes.

To address this, clinicians should adopt a goal-directed approach to oxygen therapy. This involves:

• Setting specific oxygenation targets
• Avoiding unnecessary high oxygen concentrations
• Regularly reassessing the patient’s condition

Note: By treating oxygen as a medication rather than a default intervention, clinicians can reduce the risk of hyperoxia.

Exam Relevance for Respiratory Therapy Students

For respiratory therapy students preparing for credentialing exams, hyperoxia is an important concept that is often tested in a clinical context.

Key points to understand include:

• Hyperoxia can suppress respiratory drive, especially in COPD patients
• High FiO₂ can lead to absorption atelectasis
• Oxygen toxicity is related to both concentration and duration of exposure
• Oxygen therapy should always be titrated to the lowest effective level

Note: Exam questions may present scenarios in which a patient receiving oxygen develops worsening hypercapnia or decreased respiratory effort. Recognizing hyperoxia as a contributing factor is essential for selecting the correct answer.

Integration with Other Respiratory Concepts

Hyperoxia is closely linked to several other key topics in respiratory care.

• Oxygen Therapy: Understanding how different devices deliver oxygen is essential for preventing hyperoxia. Each device has a specific range of FiO₂, and selecting the appropriate one is critical.
• Arterial Blood Gas Interpretation: ABG analysis helps identify elevated PaO₂ levels and assess the overall effectiveness of oxygen therapy. It also provides insight into ventilation and acid-base status.
• Mechanical Ventilation: Managing FiO₂ and PEEP on the ventilator requires a balance between improving oxygenation and minimizing oxygen exposure.
• Patient Assessment: Continuous monitoring of the patient’s clinical status helps identify early signs of hyperoxia and guides appropriate adjustments in therapy.

Practical Guidelines for Clinicians

To minimize the risk of hyperoxia, clinicians should follow these practical guidelines:

• Initiate oxygen therapy only when indicated
• Set clear oxygenation targets
• Monitor SpO₂ continuously and obtain ABGs when necessary
• Reduce FiO₂ as soon as oxygenation improves
• Use adjunct strategies such as PEEP to improve oxygenation
• Be cautious in patients at risk for carbon dioxide retention

Note: These steps help ensure safe and effective oxygen therapy.

Hyperoxia Practice Questions

1. What is hyperoxia?
Hyperoxia is a condition in which there are excessively high levels of oxygen in the blood and tissues.

2. What is the most common cause of hyperoxia in clinical settings?
The administration of high concentrations of supplemental oxygen.

3. At what FiO₂ level does the risk of hyperoxia significantly increase?
Typically above 0.60 to 0.70 when used for prolonged periods.

4. Why is oxygen considered a drug in respiratory care?
Because it requires proper dosing, monitoring, and adjustment to avoid harmful effects.

5. What is the primary mechanism of injury in hyperoxia?
The formation of reactive oxygen species (ROS).

6. Name three types of reactive oxygen species involved in hyperoxia.
Superoxide anions, hydrogen peroxide, and hydroxyl radicals.

7. What is oxidative stress?
A condition where excess reactive oxygen species damage cellular components.

8. Which organ is most vulnerable to oxygen toxicity?
The lungs.

9. What is hyperoxic acute lung injury (HALI)?
A form of lung injury caused by prolonged exposure to high oxygen levels.

10. What happens to alveolar epithelial cells during hyperoxia?
They become damaged or destroyed.

11. How does hyperoxia affect the pulmonary capillary endothelium?
It causes injury and increases permeability.

12. What is a consequence of increased alveolar-capillary permeability?
Pulmonary edema

13. How does hyperoxia affect lung compliance?
It decreases lung compliance, making the lungs stiffer.

14. What is pulmonary oxygen toxicity?
Lung damage caused by prolonged exposure to high oxygen concentrations.

15. What type of structural lung damage can result from hyperoxia?
Diffuse alveolar damage.

16. How does hyperoxia impair gas exchange?
By damaging alveoli and thickening alveolar membranes.

17. What is absorption atelectasis?
Collapse of alveoli due to the absorption of oxygen when nitrogen is washed out.

18. What role does nitrogen play in the alveoli?
It helps keep alveoli open by providing structural support.

19. Why does high FiO₂ increase the risk of alveolar collapse?
Because oxygen is absorbed quickly, leaving alveoli without enough gas to stay open.

20. What is one consequence of absorption atelectasis?
Reduced surface area for gas exchange.

21. How can hyperoxia worsen ventilation-perfusion mismatch?
By causing alveolar collapse and uneven ventilation.

22. What is one central nervous system symptom of oxygen toxicity?
Seizures

23. Name two additional CNS symptoms of hyperoxia.
Visual disturbances and tinnitus.

24. In what setting are CNS effects of hyperoxia more likely to occur?
Hyperbaric oxygen therapy

25. How can hyperoxia affect respiratory drive in COPD patients?
It can suppress the hypoxic drive, leading to decreased ventilation.

26. What happens to carbon dioxide levels when ventilation decreases due to hyperoxia?
PaCO₂ increases, leading to hypercapnia.

27. Why are COPD patients at risk for CO₂ retention during oxygen therapy?
Because excessive oxygen can reduce their hypoxic drive to breathe.

28. What is the recommended SpO₂ target range for most patients?
Approximately 92 percent to 96 percent.

29. What SpO₂ range is often targeted for COPD patients?
Approximately 88 percent to 92 percent.

30. What monitoring tool provides continuous, noninvasive oxygen saturation data?
Pulse oximetry

31. What is a limitation of pulse oximetry in detecting hyperoxia?
It cannot measure PaO₂ or detect excessively high oxygen levels directly.

32. What test provides direct measurement of PaO₂ and PaCO₂?
Arterial blood gas (ABG) analysis

33. What change in respiratory rate may indicate excessive oxygen administration?
A decrease in respiratory rate.

34. What is the main goal of oxygen titration?
To achieve adequate oxygenation without causing hyperoxia.

35. What is the purpose of using PEEP in oxygen therapy?
To improve oxygenation by preventing alveolar collapse.

36. How does PEEP reduce the need for high FiO₂?
By improving alveolar recruitment and gas exchange.

37. What is functional residual capacity (FRC)?
The volume of air remaining in the lungs after a normal exhalation.

38. How does PEEP affect functional residual capacity?
It increases FRC by keeping alveoli open.

39. Why should FiO₂ be reduced as soon as possible?
To minimize the risk of oxygen toxicity.

40. What is a key strategy to prevent hyperoxia in ventilated patients?
Avoid prolonged use of FiO₂ greater than 0.60.

41. What is a room air trial used for?
To assess whether a patient can maintain adequate oxygenation without supplemental oxygen.

42. What is one risk of prolonged oxygen exposure even at moderate levels?
Cumulative oxygen toxicity.

43. Why should nonrebreather masks be used cautiously?
They deliver very high oxygen concentrations.

44. What is one complication of hyperoxia in neonates?
Retinopathy of prematurity

45. What lung condition in neonates is associated with oxygen toxicity?
Bronchopulmonary dysplasia

46. Why are neonates especially sensitive to oxygen levels?
Their tissues are more vulnerable to oxidative damage.

47. What is one benefit of using a Venturi mask in COPD patients?
It delivers a precise and controlled FiO₂.

48. What type of patient setting commonly involves high oxygen exposure?
The intensive care unit (ICU).

49. What is one sign that oxygen therapy may need adjustment?
Changes in mental status.

50. What happens if oxygen therapy is not regularly reassessed?
Patients may remain exposed to excessive oxygen levels.

51. What is PaO₂?
The partial pressure of oxygen in arterial blood.

52. What happens to PaO₂ during hyperoxia?
It becomes abnormally elevated above normal levels.

53. What is one effect of reactive oxygen species on cell membranes?
They cause lipid peroxidation and membrane damage.

54. How do reactive oxygen species affect proteins?
They can alter protein structure and impair function.

55. What effect does oxidative stress have on DNA?
It can cause mutations and cellular dysfunction.

56. What type of inflammation is associated with hyperoxia?
Pulmonary inflammation

57. What happens to surfactant during prolonged oxygen exposure?
Its function is impaired or reduced.

58. Why is surfactant important in the lungs?
It reduces surface tension and prevents alveolar collapse.

59. What happens to alveoli when surfactant function is lost?
They become more prone to collapse.

60. What is one consequence of alveolar collapse?
Impaired gas exchange

61. How does hyperoxia contribute to pulmonary edema?
By increasing permeability of the alveolar-capillary membrane.

62. What happens to the alveolar-capillary membrane during hyperoxia?
It becomes damaged and more permeable.

63. What is a key feature of diffuse alveolar damage?
Thickened alveolar walls.

64. How does thickening of alveolar membranes affect oxygen diffusion?
It reduces the efficiency of gas exchange.

65. What happens to the work of breathing as lung compliance decreases?
It increases.

66. What type of ventilation problem can result from hyperoxia in COPD patients?
Hypoventilation

67. What acid-base imbalance may result from hypoventilation?
Respiratory acidosis

68. What happens to pH during respiratory acidosis?
It decreases.

69. What is one neurologic sign of severe oxygen toxicity?
Muscle twitching

70. What condition can develop if CNS oxygen toxicity progresses?
Seizures

71. What is one early symptom of CNS oxygen toxicity?
Visual disturbances

72. What role do antioxidants play in the body?
They neutralize reactive oxygen species.

73. What happens when antioxidant defenses are overwhelmed?
Oxidative damage occurs.

74. Why is prolonged FiO₂ exposure more dangerous than short-term exposure?
Because damage accumulates over time.

75. What is a key clinical responsibility when administering oxygen?
To continuously reassess and adjust therapy.

76. What is the primary goal of oxygen therapy?
To maintain adequate tissue oxygenation.

77. What happens if oxygen therapy exceeds the patient’s needs?
Hyperoxia and potential toxicity can occur.

78. What is one clinical sign of worsening gas exchange despite high FiO₂?
Persistent or worsening hypoxemia.

79. What is ventilation-perfusion mismatch?
An imbalance between air reaching the alveoli and blood flow in the lungs.

80. How does hyperoxia contribute to ventilation-perfusion mismatch?
By causing alveolar collapse and uneven ventilation.

81. What is the effect of alveolar collapse on oxygenation?
It reduces effective gas exchange.

82. What is one reason clinicians should avoid “set it and forget it” oxygen therapy?
Because patient oxygen needs can change over time.

83. What is a high-risk scenario for hyperoxia development?
Prolonged mechanical ventilation with high FiO₂.

84. Why should oxygen therapy be reassessed frequently?
To ensure it remains appropriate for the patient’s condition.

85. What is one benefit of reducing FiO₂ early?
It decreases the risk of oxygen toxicity.

86. What does SpO₂ measure?
The percentage of hemoglobin saturated with oxygen.

87. Why might SpO₂ appear normal even during hyperoxia?
Because hemoglobin can already be fully saturated at normal oxygen levels.

88. What is the relationship between FiO₂ and oxygen toxicity?
Higher FiO₂ and longer exposure increase the risk.

89. What is a safe approach to oxygen therapy in most patients?
Using the lowest effective oxygen concentration.

90. What is one reason high oxygen levels can be harmful to lung tissue?
They promote the formation of free radicals.

91. What happens to lung elasticity during oxygen toxicity?
It decreases.

92. What is one potential outcome of severe oxygen-induced lung injury?
Respiratory failure

93. What is the role of clinical judgment in oxygen therapy?
To balance oxygen needs with potential risks.

94. What is one indicator that a patient may no longer need high oxygen levels?
Improved oxygen saturation and stable ABG results.

95. What is the effect of excessive oxygen on mitochondrial function?
It can impair normal cellular respiration.

96. What is one long-term consequence of untreated hyperoxia?
Chronic lung damage

97. What type of oxygen delivery system allows for precise FiO₂ control?
A Venturi mask.

98. What is one reason hyperoxia may go unnoticed?
Lack of obvious symptoms in early stages.

99. What is a key responsibility of respiratory therapists regarding oxygen therapy?
To titrate oxygen based on patient response.

100. What is the overall principle of safe oxygen use?
Provide enough oxygen to meet needs but avoid excess.

Final Thoughts

Hyperoxia is a preventable condition that arises from excessive oxygen administration. While oxygen is essential for life, it can become harmful when delivered in high concentrations for prolonged periods. The primary mechanisms of injury involve oxidative stress, lung tissue damage, and disruption of normal respiratory control.

Clinicians must carefully balance the need to correct hypoxemia with the risk of overexposure. By using a goal-directed approach, monitoring patients closely, and adjusting therapy as needed, healthcare providers can optimize oxygen delivery while minimizing potential complications.